BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 18837884)

  • 1. Selective surgical management of well-differentiated thyroid cancer.
    Shaha A
    Ann N Y Acad Sci; 2008 Sep; 1138():58-64. PubMed ID: 18837884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implications of prognostic factors and risk groups in the management of differentiated thyroid cancer.
    Shaha AR
    Laryngoscope; 2004 Mar; 114(3):393-402. PubMed ID: 15091208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of thyroid cancer based on risk groups.
    Shaha A
    J Surg Oncol; 2006 Dec; 94(8):683-91. PubMed ID: 17131422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in the management of thyroid cancer.
    Shaha AR
    Int J Surg; 2005; 3(3):213-20. PubMed ID: 17462286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant external-beam radiotherapy in patients with high-risk well-differentiated thyroid cancer.
    Chen PV; Osborne R; Ahn E; Avitia S; Juillard G
    Ear Nose Throat J; 2009 Jul; 88(7):E01. PubMed ID: 19623515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review of thyroid cancer with intermediate differentiation.
    Sywak M; Pasieka JL; Ogilvie T
    J Surg Oncol; 2004 Apr; 86(1):44-54. PubMed ID: 15048680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors determining survival in differentiated thyroid cancer.
    Gulcelik MA; Gulcelik NE; Kuru B; Camlibel M; Alagol H
    J Surg Oncol; 2007 Dec; 96(7):598-604. PubMed ID: 17708543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Malignant transformation of thyroid cancer; poorly differentiated cancer and anaplastic cancer transformation].
    Kasai N; Sakamoto A
    Gan No Rinsho; 1983 Feb; 29(2):A-7, 105-10. PubMed ID: 6876397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of mediastinal lymph node metastasis in papillary thyroid cancer.
    Machens A; Dralle H
    Ann Surg Oncol; 2009 Jan; 16(1):171-6. PubMed ID: 18982392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Risk factors and surgical tactics in differentiated thyroid cancer].
    Barczyński M; Cichoń S; Trystuła M
    Przegl Lek; 1994; 51(10):437-42. PubMed ID: 7878198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of four prognostic indices in differentiated thyroid cancer.
    Bolaños-Gil-de-Montes F; González-Ortiz M; Vázquez-Camacho G; Ramos-Solano F
    Rev Invest Clin; 2004; 56(3):304-8. PubMed ID: 15612511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyroid cancer in young adults.
    Ying AK; Huh W; Bottomley S; Evans DB; Waguespack SG
    Semin Oncol; 2009 Jun; 36(3):258-74. PubMed ID: 19460583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of previous radiation exposure on pathologic features and clinical outcome in patients with thyroid cancer.
    Seaberg RM; Eski S; Freeman JL
    Arch Otolaryngol Head Neck Surg; 2009 Apr; 135(4):355-9. PubMed ID: 19380356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Differentiated thyroid cancers].
    Gorgone S; Campennì A; Calbo E; Catalfamo A; Sciglitano P; Sofia L; Niceta M; Borzì R; Calbo L
    G Chir; 2009; 30(1-2):26-9. PubMed ID: 19272228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of lymph nodal impairment of differentiated thyroid cancer on prognosis.
    De Andrade RP
    Rev Paul Med; 1993; 111(4):46-8. PubMed ID: 8108648
    [No Abstract]   [Full Text] [Related]  

  • 16. Surgical management of thyroid cancer.
    Ramirez AT; Gibelli B; Tradati N; Giugliano G; Zurlo V; Grosso E; Chiesa F
    Expert Rev Anticancer Ther; 2007 Sep; 7(9):1203-14. PubMed ID: 17892421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Charcoal suspension tattoo localization for differentiated thyroid cancer recurrence.
    Hartl DM; Chami L; Al Ghuzlan A; Leboulleux S; Baudin E; Schlumberger M; Travagli JP
    Ann Surg Oncol; 2009 Sep; 16(9):2602-8. PubMed ID: 19551443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome predictors and impact of central node dissection and radiometabolic treatments in papillary thyroid cancers < or =2 cm.
    Perrino M; Vannucchi G; Vicentini L; Cantoni G; Dazzi D; Colombo C; Rodari M; Chiti A; Beck-Peccoz P; Fugazzola L
    Endocr Relat Cancer; 2009 Mar; 16(1):201-10. PubMed ID: 19106146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High recurrent rate of multicentric papillary thyroid carcinoma.
    Lin JD; Chao TC; Hsueh C; Kuo SF
    Ann Surg Oncol; 2009 Sep; 16(9):2609-16. PubMed ID: 19533244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of lymphadenectomy in the management of papillary carcinoma of the thyroid.
    Rotstein L
    J Surg Oncol; 2009 Mar; 99(4):186-8. PubMed ID: 19170045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.